Here are relevant reports on : genetic-testing-market
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) & Region - Global Forecast to 2028
The global RNA therapeutics market, valued at US$32.2 billion in 2022, stood at US$13.7 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$18.0 billion by the end of the period. Growth in this market is largely driven by factors such as the increasing number of partnerships and collaborations among market players and RNA technology manufacturers, expanding modalities for RNA therapeutics, and the rising number of emergency use authorizations and approvals for COVID-19 booster vaccines.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Food Safety Testing Automation Market By Testing Type (Microbiological Testing, Chemical Testing, Physical Testing, Nutritional Testing, Others), Technology (Robotics, Software Solutions, IOT, And Sensors), End-User (Food Processors, Testing Laboratories, Regulatory Agencies), And Region - Global Forecast To 2029
The Food Safety Testing Automation Market refers to the industry focused on using automated technologies to enhance the efficiency, accuracy, and scalability of testing processes in food safety. This market is driven by increasing regulatory requirements, consumer awareness about food safety, and the rising complexity of global food supply chains.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Hematology Testing Market byTest [CBC (Hemoglobin, Hematocrit, & RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, & DPG], End User (& Clinical Testing Labs, Research Institute, & Hospital) - Global Forecasts to 2019
Emerging markets such as China, India, Brazil, and Mexico are the new revenue pockets for companies that are engaged in the development and marketing of hematology analyzers and reagents. Growing patient population, rising healthcare expenditure, and rising trends of medical tourism owing to low-cost treatments are the key factors propelling demand for hematology tests in these emerging nations.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Agricultural Testing Market by Sample (Soil, Water, Seed, Compost, Manure, Biosolids, Plant Tissue), Application (Saftey Testing, Quality Assurance), Technology (Conventional, Rapid) and Region ( North America, Europe, APAC, Row) - Global Forecast to 2028
According to MarketsandMarkets, the agricultural testing market is projected to reach USD 9.8 billion by 2028, at a CAGR of 7.1% during the forecast period. This report includes a study of the marketing and development strategies, along with the product portfolio of leading companies. These companies include SGS (Switzerland), Eurofins (Luxembourg), Intertek (UK), Bureau Veritas (France), ALS Limited (Australia), TUV Nord Group (Germany), Merieux (US), AsureQuality (New Zealand), RJ Hill Laboratories Limited (New Zealand), SCS Global (US), Agrifood Technology (Australia), APAL Agricultural Laboratory (Australia), Agvise Laboratories (US), LGC Limited (UK) and Water Agricultural Laboratories (US)
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Q-TOF Mass Spectrometry Market by Application (Biotech Applications, Pharmaceutical Applications, Food & Beverage Testing, Environmental Testing, Petrochemical Applications), and Region (North America, Europe, APAC, and Row) & Geography
The global Q-TOF mass spectrometry market is expected to grow at a CAGR of 7.7%. The growth of this market is majorly driven by the technological advancements pertaining to Q-TOF mass spectrometry technology, government initiatives for pollution control and environmental testing, high expenditure on R&D activities of mass spectrometry supplements in pharmaceutical and biotechnological applications, stringent government regulations regarding drug safety, and increased focus on producing high-quality food. However, the high costs of Q-TOF instruments is restraining the growth of the Q-TOF mass spectrometry market. Waters Corporation (US), Agilent Technologies (US), and SCIEX (Subsidiary of Danaher) (US) are the key players in the Q-TOF mass spectrometry market. Other players involved in this market are Bruker (US) and Shimadzu Corporation (Japan).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
The global legionella testing market growth is primed to transition from $296.0 million in 2022 to $439.0 million by 2027, showcasing a strong CAGR of 8.2%. The rising geriatric population, combined with the rising prevalence of legionella-related illness and rising demand for rapid diagnostics, is driving growth in this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Atomic Spectroscopy Market by Technology (Atomic Absorption Spectroscopy/X-Ray Fluorescence/X-Ray Diffraction/ICP-MS/ICP-OES) & by Application (Food & Beverage Testing/Pharmaceuticals & Biotechnology / Environmental Testing) - Analysis & Global Forecast to 2020
The atomic spectroscopy market is poised to reach USD 5.60 Billion by 2020, growing at a CAGR of 6.0% during the forecast period of 2015 to 2020. The growth of the overall atomic spectroscopy market can be contributed to rising investments, funds, and grants by government bodies worldwide and technological advancements. In addition, growing food safety concerns and stringent regulations have contributed to market growth.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Zika Virus Testing Market by Technology, (Molecular Test (Polymerase Chain Reaction, Nucleic Acid Amplification Testing), Serology Test (Elisa, Prnt), End User (Diagnostic Laboratory, Hospital, Clinics, Academic Institutes) - Global Forecast to 2023
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
EV Battery Testing Market by Testing Type (Safety, Performance), Battery Technology (Conventional Batteries, CTP, CTC), Form Factor (Cylindrical, Prismatic, Pouch), Sourcing Type, Chemistry, Propulsion, EV Type, and Region - Global Forecast to 2030
The EV battery testing market is projected to reach USD 9.51 billion in 2030 at a CAGR of 19.0% during the forecast period. The EV battery testing market is dominated by global players such as TÜV SÜD (Germany), Intertek Group plc (UK), UL LLC (US), Bureau Veritas (Belgium) and SGS Société Générale de Surveillance SA (Switzerland). These companies adopted new service launches, partnerships, collaboration, and other strategies to gain traction in the rolling stock market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
